115 related articles for article (PubMed ID: 29990695)
21. Levels of interleukin-35 and its relationship with regulatory T-cells in chronic hepatitis B patients.
Shi YY; Dai MJ; Wu GP; Zhou PP; Fang Y; Yan XB
Viral Immunol; 2015 Mar; 28(2):93-100. PubMed ID: 25494369
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B surface antigen seroclearance is uncommon but durable in the long run.
Yip TC; Brunetto MR
Hepatology; 2024 Jun; 79(6):1258-1260. PubMed ID: 38147302
[No Abstract] [Full Text] [Related]
23. CD56
Lee M; Bell CJM; Rubio Garcia A; Godfrey L; Pekalski M; Wicker LS; Todd JA; Ferreira RC
Discov Immunol; 2023; 2(1):kyad012. PubMed ID: 37649552
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 Vaccination Alters NK Cell Dynamics and Transiently Reduces HBsAg Titers Among Patients With Chronic Hepatitis B.
Shin H; Lee HS; Noh JY; Koh JY; Kim SY; Park J; Chung SW; Hur MH; Park MK; Lee YB; Kim YJ; Yoon JH; Ko JH; Peck KR; Song JY; Shin EC; Lee JH
Immune Netw; 2023 Oct; 23(5):e39. PubMed ID: 37970236
[TBL] [Abstract][Full Text] [Related]
25. Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B.
Wan Y; Mao M; Li M; Liu J; Tong X; Wang J; Li J; Yin S; Wu C
J Viral Hepat; 2024 Feb; 31(2):107-119. PubMed ID: 38146125
[TBL] [Abstract][Full Text] [Related]
26. AhR may be involved in Th17 cell differentiation in chronic hepatitis B.
Zhang R; Liu H; Lin J; Ding J; You J; Geng J
J Viral Hepat; 2023 Dec; 30(12):939-950. PubMed ID: 37608767
[TBL] [Abstract][Full Text] [Related]
27. Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome.
Miedema JR; de Jong LJ; van Uden D; Bergen IM; Kool M; Broos CE; Kahlmann V; Wijsenbeek MS; Hendriks RW; Corneth OBJ
J Autoimmun; 2023 Oct; ():103120. PubMed ID: 37863732
[TBL] [Abstract][Full Text] [Related]
28. Imbalance of peripheral blood Th17/Treg increases neutrophil-to-lymphocyte ratio in patients with dermatomyositis.
Zhang Z; Pang J; Li Y; Zuo Y; Cui X; Xu H
Am J Transl Res; 2023; 15(10):6106-6114. PubMed ID: 37969179
[TBL] [Abstract][Full Text] [Related]
29. HMGB1/PTEN/PI3K axis participates in the peripheral immune cell differentiation in two representative TCM syndromes of chronic hepatitis B patients.
Jiang C; Li X; Liu C; Li G; Zheng Y; Xie L; Wu W; Feng Q
Anat Rec (Hoboken); 2023 Dec; 306(12):3085-3096. PubMed ID: 35225421
[TBL] [Abstract][Full Text] [Related]
30. Regulatory T Cells in Hepatitis B and C Virus Infections.
Jung MK; Shin EC
Immune Netw; 2016 Dec; 16(6):330-336. PubMed ID: 28035208
[TBL] [Abstract][Full Text] [Related]
31. TH17, TH22 and Treg cells are enriched in the healthy human cecum.
Wolff MJ; Leung JM; Davenport M; Poles MA; Cho I; Loke P
PLoS One; 2012; 7(7):e41373. PubMed ID: 22829946
[TBL] [Abstract][Full Text] [Related]
32. Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo.
Giri PS; Patel SS; Dwivedi M
Hum Immunol; 2024 Jan; 85(1):110737. PubMed ID: 38057201
[TBL] [Abstract][Full Text] [Related]
33. Regulatory T cells increase in breast cancer and in stage IV breast cancer.
Wang ZK; Yang B; Liu H; Hu Y; Yang JL; Wu LL; Zhou ZH; Jiao SC
Cancer Immunol Immunother; 2012 Jun; 61(6):911-6. PubMed ID: 22116346
[TBL] [Abstract][Full Text] [Related]
34. Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB.
Yang L; Wang SY; Jiang TT; Deng W; Chang M; Wu SL; Cao WH; Lu Y; Shen G; Liu RY; Gao YJ; Xu MJ; Hu LP; Zhang L; Xie Y; Li MH
Biomed Environ Sci; 2024 Mar; 37(3):303-314. PubMed ID: 38582994
[TBL] [Abstract][Full Text] [Related]
35. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19.
Liu C; Martins AJ; Lau WW; Rachmaninoff N; Chen J; Imberti L; Mostaghimi D; Fink DL; Burbelo PD; Dobbs K; Delmonte OM; Bansal N; Failla L; Sottini A; Quiros-Roldan E; Han KL; Sellers BA; Cheung F; Sparks R; Chun TW; Moir S; Lionakis MS; ; ; Rossi C; Su HC; Kuhns DB; Cohen JI; Notarangelo LD; Tsang JS
Cell; 2021 Apr; 184(7):1836-1857.e22. PubMed ID: 33713619
[TBL] [Abstract][Full Text] [Related]
36. Local CD4+, CD8+ and CD56+ T-lymphocite Reaction on Primary Lung Cancer.
Jusufovic E; Prnjavorac B; Iljazovic E; Kosnik M; Keser D; Korosec P; Stahov J; Zukic E; Sejdinovic R; Ajanovic E
Acta Inform Med; 2011 Sep; 19(3):132-7. PubMed ID: 23408789
[TBL] [Abstract][Full Text] [Related]
37. CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients.
Nomura M; Tsuge M; Uchida T; Hiraga N; Kurihara M; Tsushima K; Fujino H; Nakahara T; Murakami E; Abe-Chayama H; Kawaoka T; Miki D; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Zhang Y; Makokha GN; Hayes CN; Tanaka S; Chayama K
J Viral Hepat; 2018 Dec; 25(12):1555-1564. PubMed ID: 29998562
[TBL] [Abstract][Full Text] [Related]
38. Unresolved issues of immune tolerance in chronic hepatitis B.
Lee HW; Chan HL
J Gastroenterol; 2020 Apr; 55(4):383-389. PubMed ID: 32016713
[TBL] [Abstract][Full Text] [Related]
39. HBV-Induced Immune Imbalance in the Development of HCC.
Chen Y; Tian Z
Front Immunol; 2019; 10():2048. PubMed ID: 31507621
[TBL] [Abstract][Full Text] [Related]
40. Combination of pegylated interferon-alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients.
Pang X; Zhang L; Liu N; Liu B; Chen Z; Li H; Chen M; Peng M; Ren H; Hu P
Clin Exp Immunol; 2020 Oct; 202(1):80-92. PubMed ID: 32638357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
